COVID-19 lockdown-related treatment modifications did not impact the outcome of digestive cancers: the Clin-COVIDICA prospective study
2025 · BMC Cancer · 1 citations
https://doi.org/10.1186/s12885-025-13787-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
47
Papers
998
Citations
15
h-index
16
i10-index
Camille Evrard is an academic researcher from Université de Poitiers. The author has contributed to research in topics: Genetic factors in colorectal cancer & Cancer Genomics and Diagnostics & Pancreatic and Hepatic Oncology Research. The author has an h-index of 15, co-authored 40 publications.
ORCID: 0000-0003-3147-1350https://doi.org/10.1186/s12885-025-13787-9
https://doi.org/10.6084/m9.figshare.8869499
https://doi.org/10.1101/2024.04.12.24305349
Click to start Chat